ArticleCancer research communications2024

Activation of the Mevalonate Pathway in Response to Anti-cancer Treatments Drives Glioblastoma Recurrences Through Activation of Rac-1.

Ling He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.